Semiconductor News & Analysis Feed
20 articles
2026-07-30
www.eenewseurope.com
2026-07-30
2026-07-28
news.google.com
2026-07-28
2026-07-27
news.google.com
2026-07-27
2026-07-27
news.google.com
2026-07-27
2026-07-27
news.google.com
2026-07-27
2026-07-27
news.google.com
2026-07-27
2026-07-27
news.google.com
2026-07-27
2026-07-27
news.google.com
2026-07-27
2026-07-21
www.engineering.com
2026-07-21
2026-07-21
www.eenewseurope.com
2026-07-21
2026-07-20
www.quiverquant.com
2026-07-20
2026-07-20
nvidianews.nvidia.com
2026-07-20
2026-07-20
finance.yahoo.com
2026-07-20
2026-07-10
developer.nvidia.com
2026-07-10
NVIDIA's release of the BioNeMo Agent Toolkit accelerates end-to-end co-folding performance, significantly advancing applications in bioinformatics and drug discovery. By integrating GPU-accelerated modules such as MSA generation, co-folding inference, serving, and multi-GPU scaling, the toolkit add
2026-06-27
finance.yahoo.com
2026-06-27
NVIDIA (NVDA) unveiled the BioNeMo Agent Toolkit on June 23, 2026, aimed at accelerating scientific discovery in life sciences through artificial intelligence. The toolkit integrates over a decade of NVIDIA's libraries and models, enabling AI systems to perform complex tasks such as protein design,
2026-06-25
www.news-medical.net
2026-06-25
NVIDIA announced the BioNeMo Agent Toolkit on June 25, 2026, designed to accelerate scientific discovery in life sciences by providing domain-specific AI tools. The toolkit integrates over a decade of NVIDIA's life sciences libraries, tools, and open models, enabling AI agents, scientists, and labs
2026-06-24
www.hpcwire.com
2026-06-24
NVIDIA's announcement of the BioNeMo agent toolkit represents a significant advancement in AI-driven scientific discovery. This innovative toolset provides researchers with specialized agent frameworks that dramatically accelerate computational processes in biotechnology and drug discovery applicati
2026-06-24
www.rdworldonline.com
2026-06-24
NVIDIA's announcement of the BioNeMo agent toolkit represents a significant advancement in AI application within the biopharmaceutical sector. The platform has garnered support from nearly 50 major partners including Eli Lilly, Thermo Fisher, and Dassault Systèmes, demonstrating strong industry adop
2026-06-23
www.genengnews.com
2026-06-23
NVIDIA's launch of the Science Reasoning AI Suite and BioNeMo agent toolkit marks a significant advancement in AI's application within biotechnology. This development demonstrates NVIDIA's technological prowess in AI chips and computing platforms, positioning artificial intelligence as a transformat
2026-06-23
www.genengnews.com
2026-06-23
NVIDIA's launch of its new scientific reasoning AI suite and BioNeMo agent toolkit represents a significant advancement in AI applications within biotechnology. This development demonstrates NVIDIA's continued innovation in AI computing platforms while highlighting the growing convergence between se